CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
Sangmo Hong, Chang Hee Jung, Song Han, Cheol-Young Park
Diabetes Metab J. 2022;46(1):63-70.   Published online April 19, 2021
DOI: https://doi.org/10.4093/dmj.2020.0253

Excel Download

Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
Diabetes & Metabolism Journal. 2022;46(1):63-70   Crossref logo
Link1 Link2 Link3

Dipeptidyl peptidase IV inhibitors
Meyler's Side Effects of Drugs. 2016;1003   Crossref logo
Link1 Link2

The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
Clinical Science. 2018;132(4):489-507   Crossref logo
Link1 Link2

Correction: The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
Clinical Science. 2019;133(1):151-151   Crossref logo
Link1 Link2

Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors
Diabetologia. 2012;55(10):2848-2849   Crossref logo
Link1 Link2 Link3

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
Cellular Metabolism and Related Disorders. 2020;   Crossref logo
Link1

Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter
FEBS Journal. 2011;278(18):3256-3276   Crossref logo
Link1 Link2

Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin
Journal of the European Academy of Dermatology and Venereology. 2011;26(2):249-253   Crossref logo
Link1 Link2

Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy
Drug, Healthcare and Patient Safety. 2010;7   Crossref logo
Link1

What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
Diabetologia. 2005;48(4):605-607   Crossref logo
Link1 Link2 Link3